American Society of Hirudotherapy

Leech therapy for patients with surgically unsalvageable venous obstruction after revascularized free tissue transfer

Prospective protocol published in Arch Otolaryngol Head Neck Surg (2002)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportClinical TrialsChepeha DB et al. · Archives of otolaryngology--head & neck surgery, 2002

Abstract

OBJECTIVE: To assess the efficacy and associated complications of a leech therapy protocol used for patients with a head and neck free tissue transfer in whom flap viability is threatened because of surgically unsalvageable venous obstruction. DESIGN: Medical record review of a prospective protocol. SETTING: Tertiary care academic medical center. PATIENTS: Of the 450 free tissue transfers to the head and neck region performed by our microvascular program from January 1, 1995, to October 31, 2000, 8 patients (1.8%) developed venous obstruction not considered salvageable by conventional surgical or thrombolytic therapy. INTERVENTIONS: All 8 patients were placed on a protocol using leeches (Hirudo medicinalis), intensive care unit monitoring, antithrombotic pharmacotherapy, frequent hematologic evaluation, blood transfusions as needed, and antibiotic prophylaxis for Aeromonas hydrophila. MAIN OUTCOME MEASURES: Flap salvage rate, number of leeches used per patient, time needed for inosculation, duration of intensive care unit admission, transfusion requirement per patient, and complications during leech therapy. RESULTS: All 8 flaps survived with the application of this protocol. An average of 215 leeches were used per patient, and the average time needed for inosculation was 6.6 days. The average duration in the intensive care unit was 9.6 days. The morbidity of our protocol was substantial, with intensive care unit psychosis, prerenal azotemia, and large transfusion requirements being the most frequent complications. An average of 13 U of packed red blood cells per patient was necessary. CONCLUSIONS: Aggressive application of the presented leech therapy protocol can salvage free tissue transfers with venous obstruction that are otherwise unsalvageable. The associated morbidity can be marked. Thus, judicious application of this protocol for flap preservation is essential.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAgedFemaleGraft Occlusion, VascularGraft SurvivalHeadHumansLeechingMaleMiddle AgedNeckRetrospective StudiesSalvage Therapy

Summary

Eight patients with surgically unsalvageable venous obstruction after head and neck free tissue transfer: all 8 flaps survived using an ICU-based leech protocol. Mean of 215 leeches per patient, mean 6.6 days to inosculation, mean 13 units packed RBCs.

Why This Matters for Hirudotherapy

Defines a high-intensity protocol for the most challenging flap salvage scenarios — demonstrates feasibility but substantial morbidity.

Citation

Leech therapy for patients with surgically unsalvageable venous obstruction after revascularized free tissue transfer.

Chepeha DB et al. · Archives of otolaryngology--head & neck surgery, 2002

Added to ASH library: May 26, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.